These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20567109)
1. [Compliance of oral UFT plus leucovorin adjuvant chemotherapy in patients who underwent curative resection for colorectal cancer]. Tsunoda A; Nakao K; Watanabe M Gan To Kagaku Ryoho; 2010 Jun; 37(6):1065-8. PubMed ID: 20567109 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV. Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients]. Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484 [TBL] [Abstract][Full Text] [Related]
4. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer]. Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin. Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907 [TBL] [Abstract][Full Text] [Related]
6. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205. Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736 [TBL] [Abstract][Full Text] [Related]
7. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
8. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
9. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials. Bin Q; Li J; Liao C; Cao Y; Gao F Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863 [TBL] [Abstract][Full Text] [Related]
10. [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer]. Sakuyama T; Yokoyama M; Ogawa M; Takao Y; Sato K; Kawahara H; Anazawa S; Yamazaki Y; Hirai K Gan To Kagaku Ryoho; 2004 May; 31(5):771-5. PubMed ID: 15170991 [TBL] [Abstract][Full Text] [Related]
11. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer. Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459 [TBL] [Abstract][Full Text] [Related]
12. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M J BUON; 2007; 12(2):203-8. PubMed ID: 17600873 [TBL] [Abstract][Full Text] [Related]
13. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer. Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025 [TBL] [Abstract][Full Text] [Related]
14. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule. Pazdur R; Lassere Y; Diaz-Canton E; Ho DH Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517 [TBL] [Abstract][Full Text] [Related]
16. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma. Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795 [TBL] [Abstract][Full Text] [Related]
18. [European Organization for Research and Treatment of Cancer QLQ-C30 and functional assessment of cancer therapy- general for measurement of quality of life in colorectal cancer patients who received adjuvant chemotherapy- a comparison]. Tsunoda A Gan To Kagaku Ryoho; 2010 Sep; 37(9):1719-24. PubMed ID: 20841934 [TBL] [Abstract][Full Text] [Related]
19. [Phase I study of orally administered UFT plus l-leucovorin]. Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299. Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]